Noxafil antifungal agent for invasive Aspergillus and Candida prophylaxis gets FDA approval
PRESS RELEASE The U.S. Food and Drug Administration has approved NOXAFIL® (posaconazole) injection (18 mg/ mL), a new formulation of NOXAFIL for intravenous (IV) use. Merck’s antifungal agent is also marketed More...